BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30539313)

  • 1. Fatigue in survivors of malignant melanoma and its determinants: a register-based cohort study.
    Tibubos AN; Ernst M; Brähler E; Fischbeck S; Hinz A; Blettner M; Zeissig SR; Weyer V; Imruck BH; Binder H; Beutel ME
    Support Care Cancer; 2019 Aug; 27(8):2809-2818. PubMed ID: 30539313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression, anxiety and quality of life in long-term survivors of malignant melanoma: a register-based cohort study.
    Beutel ME; Fischbeck S; Binder H; Blettner M; Brähler E; Emrich K; Friedrich-Mai P; Imruck BH; Weyer V; Zeissig SR
    PLoS One; 2015; 10(1):e0116440. PubMed ID: 25615573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of illness-specific social support and its relation to distress in long-term melanoma survivors.
    Fischbeck S; Weyer-Elberich V; Zeissig SR; Imruck BH; Blettner M; Binder H; Beutel ME
    BMC Public Health; 2018 Apr; 18(1):511. PubMed ID: 29665805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-efficacy for coping with cancer in melanoma patients: its association with physical fatigue and depression.
    Albrecht K; Droll H; Giesler JM; Nashan D; Meiss F; Reuter K
    Psychooncology; 2013 Sep; 22(9):1972-8. PubMed ID: 23288588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of physical, affective, and cognitive fatigue during breast cancer therapy and 12 months follow-up.
    Schmidt ME; Wiskemann J; Schneeweiss A; Potthoff K; Ulrich CM; Steindorf K
    Int J Cancer; 2018 Mar; 142(6):1148-1157. PubMed ID: 29082588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptom Severity and Quality of Life Among Long-term Colorectal Cancer Survivors Compared With Matched Control Subjects: A Population-Based Study.
    Hart TL; Charles ST; Gunaratne M; Baxter NN; Cotterchio M; Cohen Z; Gallinger S
    Dis Colon Rectum; 2018 Mar; 61(3):355-363. PubMed ID: 29377871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of quality of life in melanoma patients 4 years after diagnosis: Results of a nationwide cohort study in Germany.
    Krajewski C; Benson S; Elsenbruch S; Schadendorf D; Livingstone E
    J Psychosoc Oncol; 2018; 36(6):734-753. PubMed ID: 30321123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-reported outcomes in cancer survivors: a population-wide cross-sectional study.
    Jefford M; Ward AC; Lisy K; Lacey K; Emery JD; Glaser AW; Cross H; Krishnasamy M; McLachlan SA; Bishop J
    Support Care Cancer; 2017 Oct; 25(10):3171-3179. PubMed ID: 28434095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptom cluster of emotional distress, fatigue and cognitive difficulties among young and older breast cancer survivors: The mediating role of subjective stress.
    Levkovich I; Cohen M; Alon S; Kuchuk I; Nissenbaum B; Evron E; Pollack S; Fried G
    J Geriatr Oncol; 2018 Sep; 9(5):469-475. PubMed ID: 29759914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with social functioning among long-term cancer survivors treated with hematopoietic stem cell transplantation as adolescents or young adults.
    Walsh CA; Yi JC; Rosenberg AR; Crouch MV; Leisenring WM; Syrjala KL
    Psychooncology; 2020 Oct; 29(10):1579-1586. PubMed ID: 32628342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related differences in health-related quality of life among thyroid cancer survivors compared with a normative sample: Results from the PROFILES Registry.
    Mols F; Schoormans D; Smit JWA; Netea-Maier RT; Links TP; van der Graaf WTA; Husson O
    Head Neck; 2018 Oct; 40(10):2235-2245. PubMed ID: 29756245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avoidant coping and self-efficacy mediate relationships between perceived social constraints and symptoms among long-term breast cancer survivors.
    Adams RN; Mosher CE; Cohee AA; Stump TE; Monahan PO; Sledge GW; Cella D; Champion VL
    Psychooncology; 2017 Jul; 26(7):982-990. PubMed ID: 26969374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Illness-related distress in women with clinically localized cutaneous melanoma.
    Atkinson TM; Noce NS; Hay J; Rafferty BT; Brady MS
    Ann Surg Oncol; 2013 Feb; 20(2):675-9. PubMed ID: 22965568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of quality of life in newly diagnosed melanoma and breast cancer patients.
    Lehto US; Ojanen M; Kellokumpu-Lehtinen P
    Ann Oncol; 2005 May; 16(5):805-16. PubMed ID: 15817599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical, demographic and psychological correlates of fear of cancer recurrence (FCR) morbidity in breast, colorectal and melanoma cancer survivors with probable clinically significant FCR seeking psychological treatment through the ConquerFear study.
    Smith A'; Sharpe L; Thewes B; Turner J; Gilchrist J; Fardell JE; Girgis A; Tesson S; Descallar J; Bell ML; Beith J; Butow P;
    Support Care Cancer; 2018 Dec; 26(12):4207-4216. PubMed ID: 29882025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychological characteristics of early-stage melanoma patients: a cross-sectional study on 204 patients.
    Tesio V; Ribero S; Castelli L; Bassino S; Leombruni P; Caliendo V; Grassi M; Lauro D; Macripò G; Torta RGV
    Melanoma Res; 2017 Jun; 27(3):277-280. PubMed ID: 28207426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthy life styles, sleep and fatigue in endometrial cancer survivors: A cross-sectional study.
    Yu CH; Wang TJ; Chang CL; Liang SY; Wu SF; Liu CY; Lu YY
    J Clin Nurs; 2020 Apr; 29(7-8):1372-1380. PubMed ID: 31970842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of the quality of life in Chinese breast cancer survivors.
    Xia J; Tang Z; Deng Q; Yang R; Wang J; Yu J
    Breast Cancer Res Treat; 2018 Jan; 167(2):537-545. PubMed ID: 28965272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lived Experiences and Fear of Cancer Recurrence Among Survivors of Localized Cutaneous Melanoma.
    Mahama AN; Haller CN; Labrada J; Idiong CI; Haynes AB; Jacobs EA; Tsevat J; Pignone MP; Adamson AS
    JAMA Dermatol; 2024 May; 160(5):495-501. PubMed ID: 38353983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive Function, Psychosocial Outcome, and Health-Related Quality of Life of the First-Generation Metastatic Melanoma Survivors Treated with Ipilimumab.
    Rogiers A; Leys C; Lauwyck J; Schembri A; Awada G; Schwarze JK; De Cremer J; Theuns P; Maruff P; De Ridder M; Bernheim JL; Neyns B
    J Immunol Res; 2020; 2020():2192480. PubMed ID: 32775464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.